In this chapter:

1. (1) “Blood lead test” means the determination by a clinical laboratory of the amount of lead in a blood sample.
2. (2) “Blood sample” means any human blood sample, venous or capillary, drawn for analysis of the concentration of lead in the blood.
3. (3) “Clinical laboratory” means a laboratory which analyzes human blood samples to determine the concentration of lead in blood and which meets the standards of the clinical laboratory improvement amendments.
4. (4) “Clinical laboratory improvement amendments” means the federal clinical laboratory improvement amendments of 1988, as amended, 42 USC 263a and 42 CFR Part 493.
5. (5) “Department” means the Wisconsin department of health services.
6. (6) “Director of a blood drawing site” means a person responsible for a location where blood samples are obtained or drawn to determine the concentration of lead in the blood.
7. (7) “Health care provider” means a physician, nurse, hospital administrator, local health officer or director of a blood drawing site.
8. (8) “Local health department” has the meaning specified under s. 250.01 (4), Stats.
9. (9) “Local health officer” means the person in charge of a local health department.
10. (10) “Lead poisoning or lead exposure” means a level of lead in the blood of 3.5 or more micrograms per 100 milliliters of blood.

History

History: Cr. Register, May, 2000, No. 533, eff. 6-1-00; corrections in (5) and (11) made under s. 13.92 (4) (b) 6. and 7., Stats., Register January 2009 No. 637; CR 19-019: am. (10), r. (11) to (13) Register December 2019 No. 768, eff. 1-1-20; EmR2502: emerg. am. (10), eff. 1-31-25; CR 24-082: am. (10) Register July 2025 No. 835, eff. 8-1-25.